glp 1 gi side effects Gastrointestinal (GI) of GLP-1 Receptor Agonists —Semaglutide —Liraglutide —Dulaglutide Glucagon-Like Peptide-1 Agonist Use in

Cannabis While no pre-clinical or mechanistic study has considered GLP-1RAs for cannabis misuse so far, a large epidemiological investigation has recently noted an association between semaglutide use and fewer cannabis-use disorders in both patients with T2DM ( N = 596,045) and patients with obesity ( N = 85,223) over a 1-year follow-up 114

Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk

Side-effect management is highly individual many patients do better with slower titration than the label schedule

If youre curious about which option is best for you, contact us today to schedule an appointment

R., Lingvay, I., Ldemann, J., Andreassen, C., Navarria, A., & Viljoen, A

For weight management, be aware that in the UK, GLP-1 medications like Wegovy (semaglutide) and Saxenda (liraglutide) are typically only available through specialist weight management services (tier 3 or 4), with specific BMI thresholds and time-limited treatment courses as per NICE guidance